Annual EBITDA
-$85.89 M
-$29.71 M-52.87%
December 31, 2023
Summary
- As of February 8, 2025, CARM annual EBITDA is -$85.89 million, with the most recent change of -$29.71 million (-52.87%) on December 31, 2023.
- During the last 3 years, CARM annual EBITDA has fallen by -$57.96 million (-207.53%).
- CARM annual EBITDA is now -207.53% below its all-time high of -$27.93 million, reached on December 1, 2020.
Performance
CARM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$12.41 M
-$992.00 K-8.69%
September 30, 2024
Summary
- As of February 8, 2025, CARM quarterly EBITDA is -$12.41 million, with the most recent change of -$992.00 thousand (-8.69%) on September 30, 2024.
- Over the past year, CARM quarterly EBITDA has increased by +$9.24 million (+42.69%).
- CARM quarterly EBITDA is now -24.84% below its all-time high of -$9.94 million, reached on March 1, 2022.
Performance
CARM Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$63.37 M
+$9.24 M+12.73%
September 30, 2024
Summary
- As of February 8, 2025, CARM TTM EBITDA is -$63.37 million, with the most recent change of +$9.24 million (+12.73%) on September 30, 2024.
- Over the past year, CARM TTM EBITDA has increased by +$17.34 million (+21.48%).
- CARM TTM EBITDA is now -537.62% below its all-time high of -$9.94 million, reached on March 1, 2022.
Performance
CARM TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
CARM EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -52.9% | +42.7% | +21.5% |
| 3 y3 years | -207.5% | +25.0% | -12.8% |
| 5 y5 years | -207.5% | +25.0% | -12.8% |
CARM EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -114.1% | at low | -24.8% | +44.3% | -537.6% | +26.2% |
| 5 y | 5-year | -207.5% | at low | -24.8% | +44.3% | -537.6% | +26.2% |
| alltime | all time | -207.5% | at low | -24.8% | +44.3% | -537.6% | +26.2% |
Carisma Therapeutics EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$12.41 M(+8.7%) | -$63.37 M(-12.7%) |
| Jun 2024 | - | -$11.41 M(-35.9%) | -$72.61 M(-10.8%) |
| Mar 2024 | - | -$17.82 M(-18.0%) | -$81.44 M(-5.2%) |
| Dec 2023 | -$85.89 M | -$21.73 M(+0.4%) | -$85.89 M(+6.4%) |
| Sep 2023 | - | -$21.65 M(+6.9%) | -$80.70 M(+7.5%) |
| Jun 2023 | - | -$20.25 M(-9.1%) | -$75.08 M(+9.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | -$22.27 M(+34.7%) | -$68.52 M(+21.9%) |
| Dec 2022 | -$56.19 M(+40.1%) | -$16.54 M(+3.2%) | -$56.19 M(+41.7%) |
| Sep 2022 | - | -$16.03 M(+17.1%) | -$39.65 M(+67.8%) |
| Jun 2022 | - | -$13.69 M(+37.7%) | -$23.63 M(+137.7%) |
| Mar 2022 | - | -$9.94 M | -$9.94 M |
| Dec 2021 | -$40.11 M(+43.6%) | - | - |
| Dec 2020 | -$27.93 M | - | - |
FAQ
- What is Carisma Therapeutics annual EBITDA?
- What is the all time high annual EBITDA for Carisma Therapeutics?
- What is Carisma Therapeutics annual EBITDA year-on-year change?
- What is Carisma Therapeutics quarterly EBITDA?
- What is the all time high quarterly EBITDA for Carisma Therapeutics?
- What is Carisma Therapeutics quarterly EBITDA year-on-year change?
- What is Carisma Therapeutics TTM EBITDA?
- What is the all time high TTM EBITDA for Carisma Therapeutics?
- What is Carisma Therapeutics TTM EBITDA year-on-year change?
What is Carisma Therapeutics annual EBITDA?
The current annual EBITDA of CARM is -$85.89 M
What is the all time high annual EBITDA for Carisma Therapeutics?
Carisma Therapeutics all-time high annual EBITDA is -$27.93 M
What is Carisma Therapeutics annual EBITDA year-on-year change?
Over the past year, CARM annual EBITDA has changed by -$29.71 M (-52.87%)
What is Carisma Therapeutics quarterly EBITDA?
The current quarterly EBITDA of CARM is -$12.41 M
What is the all time high quarterly EBITDA for Carisma Therapeutics?
Carisma Therapeutics all-time high quarterly EBITDA is -$9.94 M
What is Carisma Therapeutics quarterly EBITDA year-on-year change?
Over the past year, CARM quarterly EBITDA has changed by +$9.24 M (+42.69%)
What is Carisma Therapeutics TTM EBITDA?
The current TTM EBITDA of CARM is -$63.37 M
What is the all time high TTM EBITDA for Carisma Therapeutics?
Carisma Therapeutics all-time high TTM EBITDA is -$9.94 M
What is Carisma Therapeutics TTM EBITDA year-on-year change?
Over the past year, CARM TTM EBITDA has changed by +$17.34 M (+21.48%)